Phase I clinical and pharmacokinetic trial of irofulven.
Thomas JP, Arzoomanian R, Alberti D, Feierabend C, Binger K, Tutsch KD, Steele T, Marnocha R, Smith C, Smith S, MacDonald J, Wilding G, Bailey H.
Thomas JP, et al. Among authors: marnocha r.
Cancer Chemother Pharmacol. 2001 Dec;48(6):467-72. doi: 10.1007/s002800100365.
Cancer Chemother Pharmacol. 2001.
PMID: 11800027
Clinical Trial.